Welcome to Lumino’s Media Hub.

Here you’ll find everything you need to stay in the loop with our latest news, updates, and resources.

Join us. Let’s make better mental health for everyone.

Becky Cotton and Mo Morgan

Co-Founders

Lumino Day 2-115.jpg

How to contact us

For media enquiries, interviews, or more information, get in touch with our media team. We’re here to help with expert commentary, speaker appearances, or whatever else you might need.

For all enquiries, get in touch with the team at 📧 [email protected] or by calling us direct on +44 (0)117 2449010.

Press Kit

For photos, logos and so on: Download here.

News

Want to know what we’ve been up to? We post all our news on our LinkedIn page. See how we’re shaking things up in digital health.

About us

About Lumino

https://s3-us-west-2.amazonaws.com/secure.notion-static.com/b33ac2e1-75ba-443c-a040-915e4cbe58f6/better-mental-health.png

Lumino is on a mission to bring better mental health to everyone.

Right now, one in five people are experiencing a mental health problem. However, most will have not have access to effective treatment.

Our goal is to reinvent how mental health treatment is delivered, through developing world-leading digital therapeutic programmes. We combine a strong focus on clinical outcomes with great design and engaging content. Through this, we can make evidence-based interventions available to millions in a truly scalable way.

Lumino is supported by a brilliant range of partner organisations. Our work is supported by NIHR, Innovate UK, Bayer and the Scottish Government. Our first product, currently in development, focuses on supporting women's health.

About Seren

In the UK, 2.5 million people are currently experiencing significant menopausal symptoms. Symptoms can last 7 years or more, including hot flushes, night sweats, anxiety, fatigue and sleep problems. 60% say it has affected them at work.

Cognitive Behavioural Therapy is proven to help. It is recommended by both the British and North American Menopause Societies. However, access is poor.

But what if we could leverage the power of digital therapeutics to close the treatment gap? Supported by Innovate UK, NIHR, Bayer and the Scottish Government, Seren is our prototype digital therapeutic to help patients experiencing such symptoms.